TURKISH JOURNAL OF HEMATOLOGY, vol.31, no.3, pp.276-285, 2014 (SCI-Expanded)
Article / Article
TURKISH JOURNAL OF HEMATOLOGY
Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Cytomegalovirus reactivation, Human leukocyte antigens, Allogeneic stem cell transplantation, Graft-versus-host disease, Prognosis, CMV scoring index, CYTOTOXIC T-LYMPHOCYTES, VERSUS-HOST-DISEASE, ADOPTIVE IMMUNOTHERAPY, PREEMPTIVE GANCICLOVIR, PREGNANT-WOMEN, CMV INFECTION, VIRUS, DONOR, RECIPIENT, PROPHYLAXIS
Gazi University Affiliated:
Objective: Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation (AHSCT) recipients. Current practice includes prophylactic and preemptive treatment modalities, which have risks, side effects, and costs of their own. There is no established risk scoring system that applies to all patients. We aimed to investigate the risk factors for CMV reactivation in AHSCT recipients.